NPI registry status
Active
2026 NPPES data Gynecologic Oncology Physician NPI 1447201827
Verify on CMS → John Villeneuve
Gynecologic Oncology Physician in West Reading, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,364 in Gynecologic Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
314
Medicare Part D claims · 82 beneficiaries · Gynecologic Oncology Physician avg: 188
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
86.1/100
▲ 3 pts above national avg 83.1 · Above neutral
Industry payments
$121.68
5 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
John Villeneuve reported a CMS MIPS final score of 86.1/100 - above the 83.1 national average - and filed 314 Medicare Part D claims in 2023.
- 86.1/100
- MIPS score · +3 vs avg
- 314
- Part D claims, 2023
- 78%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
John Villeneuve's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
86 Top 48% higher than 52% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where John Villeneuve sits
This provider among gynecologic oncology physician peers
Across the 446 gynecologic oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, John Villeneuve writes more Part D claims than 78% of them and scores higher on MIPS quality than 49% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one gynecologic oncology physician peer from a representative sample of 60; the gold marker is John Villeneuve. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
John Villeneuve practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about John Villeneuve?
High performer (top quartile)Primary specialty
Gynecologic Oncology Physician
Medicare Part D claims
314 67% vs specialty avg
MIPS final score
86.1/100 3 pts vs avg
Specialty distribution in Pennsylvania
How Gynecologic Oncology Physician compares to other specialties among Pennsylvania providers
Medicare quality performance, MIPS
John Villeneuve's 2023 MIPS final score plotted against the Gynecologic Oncology Physician national average
- MIPS Final Score
- 86.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Gynecologic Oncology Physician) - 86.1/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
John Villeneuve appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider at 6TH AVENUE AND SPRUCE STREET, West Reading, PA, 19611, with a listed phone of (610) 988-8905. NPI 1447201827 was issued on 05/12/2006.
Medicare Part D records for calendar year 2023 show 314 prescription claims written by this provider, covering 82 Medicare beneficiaries and totaling roughly $708K in drug spend, split 22% brand-name and 78% generic by claim count, with an opioid prescribing rate of 16.2%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86.1/100 for the 2023 performance year (Quality 81.9, Cost 62.8), compared with the national average of 83.1.
Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,364 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1447201827 |
|---|---|
| Specialty | Gynecologic Oncology Physician |
| Gender | Male |
| NPI Issued | 05/12/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
86.1318
Final Score
Avg: 83.1
81.9126
Quality
62.8334
Cost
99
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where John Villeneuve bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Reading Hospital
★★★★☆ 4/5
West Reading, PA
Acute Care Hospitals
CMS CCN: 390044
Keystone Rehabilitation Systems Inc
Birdsboro, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for John Villeneuve. Source: openpaymentsdata.cms.gov.
Total received
$122
Largest payer
Incyte Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to John Villeneuve. To verify John Villeneuve's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
John Villeneuve - brand share 22.0%
Gynecologic Oncology Physician average
22% brand-name claims vs 78% generic, on 314 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
314
Total Claims
$708K
Total Drug Cost
82
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 356
- Total Day Supply
- 6,584
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $703K
- Generic Drug Cost
- $5K
- Opioid Claims
- 51 (16.2% rate)
Patient Demographics
- Average Patient Age
- 71.2 years
- Avg HCC Risk Score
- 1.49
- Gender Split
- 100% female / 0% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What John Villeneuve prescribes most
Top Medicare Part D drugs by claim count, 2023
- Zejula
Zejula
46 claims
- Prochlorperazine M…
Prochlorperazine Maleate
44 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
40 claims
- Ondansetron Hcl
Ondansetron Hcl
32 claims
- Clobetasol Propion…
Clobetasol Propionate
22 claims
- Dexamethasone
Dexamethasone
20 claims
- Enoxaparin Sodium
Enoxaparin Sodium
19 claims
- Lidocaine-Prilocaine
Lidocaine-Prilocaine
19 claims
| Drug | Claims |
|---|---|
| Zejula Niraparib Tosylate | 46 |
| Prochlorperazine Maleate | 44 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 40 |
| Ondansetron Hcl | 32 |
| Clobetasol Propionate | 22 |
| Dexamethasone | 20 |
| Enoxaparin Sodium | 19 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 19 |
| Anastrozole | 15 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gynecologic Oncology Physician Overview
How John Villeneuve fits within the Gynecologic Oncology Physician landscape nationally.
1,364
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider
John Villeneuve's 314 claims are above the specialty average of 188.
Nearby Gynecologic Oncology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Villeneuve.
Dr. Nawar Abdul Latif
M.D.
Philadelphia, PA
Dr. Gazi Abdulhay
MD
Upland, PA
Dr. Allison Ball
M.D.
Wilkes Barre, PA
Jessica Berger
Pittsburgh, PA
Michelle Boisen
Pittsburgh, PA
Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Pennsylvania medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Gynecologic Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Pennsylvania
Frequently Asked Questions
What is John Villeneuve's specialty? ▼
John Villeneuve specializes in Gynecologic Oncology Physician and practices in West Reading, Pennsylvania.
How much does John Villeneuve prescribe under Medicare Part D? ▼
In 2023, John Villeneuve wrote 314 Medicare Part D claims totaling $708K in drug costs for 82 beneficiaries.
What is John Villeneuve's Medicare quality score? ▼
John Villeneuve has a CMS MIPS Final Score of 86.1/100 (Quality: 81.9, Cost: 62.8). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is John Villeneuve located? ▼
John Villeneuve is located at 6TH AVENUE AND SPRUCE STREET, West Reading, PA, 19611. Phone: (610) 988-8905.
What is John Villeneuve's NPI number? ▼
John Villeneuve's National Provider Identifier (NPI) is 1447201827, issued on 05/12/2006.
Does John Villeneuve prescribe more brand-name or generic drugs? ▼
John Villeneuve's prescribing is 22% brand-name and 78% generic drugs by claim count, with $703K in brand drug costs.
Does John Villeneuve prescribe opioids? ▼
Yes, John Villeneuve had 51 opioid claims in 2023 with an opioid prescribing rate of 16.2%.
How many Gynecologic Oncology Physician providers are there in the US? ▼
There are 1,364 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does John Villeneuve prescribe most often? ▼
Based on 2023 Medicare Part D data, John Villeneuve's most frequently prescribed drugs include Zejula, Prochlorperazine Maleate, Oxycodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does John Villeneuve accept Medicare? ▼
John Villeneuve appears in CMS Medicare data with 314 Part D claims and 82 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify John Villeneuve's credentials? ▼
John Villeneuve's NPI is 1447201827. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.